Germany· DE-A57-dfc186e8396d6658
Reisetabletten
A dimenhydrinate product containing dimenhydrinate, registered in Germany by 1 A Pharma Gmbh. The same ATC class is registered in 9 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Dimenhydrinate is registered in 9 of 19 countries.
Countries holding a registration under ATC R06AA11 (dimenhydrinate), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 4 of them publish a price we can compare per daily dose
Dimenhydrinate · ATC R06AA11
9 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Franceprice
- Germany
- Japan
- Norwayprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dimenhydrinate costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dimenhydrinate · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- US United States$0.34 (acquisition cost)
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Dimenhydrinate
- Manufacturer
- 1 A Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- R06AA11
- ATC class
- Dimenhydrinate
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
85 interactions on record for dimenhydrinate.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dimenhydrinate · interactions on record
85 records
- 3 severe
- 81 moderate
- 1 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- DicycloverineA03AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dimenhydrinate in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAirmit AceSato Pharmaceutical Co., Ltd.
- CanadaANTI-NAUSEANTVITA HEALTH PRODUCTS INC
- SpainBIODRAMINA 100 mg SUPOSITORIOSUriach Aquilea Otc, S.L.
- NorwayDimenhydrinat aluidAliud Pharma
- BelgiumArlevertan 20 mg - 40 mgHennig Arzneimittel
- PolandAviomarinTeva Pharmaceuticals Polska Sp. z o.o.
- United KingdomDimenhydrinate 12.5mg/5ml oral solutionSpecial Order
- FranceNAUSICALM 15,7 mg ENFANTS, sirop en sachetBROTHIER
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Travelgum, Vertirosan
- Belgium · R Calm, R Calm Dimenhydrinate
- Bulgaria · Вомакур, Дименхидринат Актавис
- Cyprus · Oriens Vom, Travelgum 20mg
- Denmark · Dimenhydrinat Galenica
- Spain · Biodramina, Biodramina Infantil
- France · Nausicalm, Nausicalm Adultes
- United Kingdom (Northern Ireland) · Travlese
- Greece · Travelgum 20mg, Vomex-A
- Croatia · Dramina
- Hungary · Daedalon, Daedalon Kid
- Italy · Lomarin, Novago
- Luxembourg · Dimenhydrinat Hameln, Vomex A
- Latvia · Vertirosan
- Malta · Biodramina, Vomidrine
- Poland · Aviomarin
- Portugal · Draminal, Enjomin
- Romania · Oriens
- Sweden · Calma
- Slovenia · Dramina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b4cf0650-3bac-4393-b4c9-fd6336b93672 GET /v1/drugs/b4cf0650-3bac-4393-b4c9-fd6336b93672?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Dimenhydrinate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about dimenhydrinate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.